INZY20250516C7.5
INZY May 16 2025 7.50 Call (INZY250516C00007500)
option OPRA

we are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. our area of expertise is in disorders of paradoxical mineralization and our lead drug is an enzyme replacement therapy in pre-clinical development.